Cargando…

LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis

Glioblastoma (GBM) belongs to the high‐grade (IV) gliomas with extremely poor prognosis. Accumulating evidence uncovered the key roles of long non‐coding RNAs (lncRNAs) in GBM development. This study aimed to determine the biological actions and the clinical relevance of lncRNA MIR4435‐2 Host Gene (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hongchao, Zhang, Beilin, Yang, Yinggui, Li, Zihuang, Zhao, Pan, Wu, Weiqing, Zhang, Huirong, Mao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294147/ https://www.ncbi.nlm.nih.gov/pubmed/32319715 http://dx.doi.org/10.1111/jcmm.15280

Ejemplares similares

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
por: Xiao, Yu, et al.
Publicado: (2019)

LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging
por: Liu, Yingli, et al.
Publicado: (2020)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
por: Chen, Zhou, et al.
Publicado: (2023)

lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1
por: Zhang, Hui, et al.
Publicado: (2019)

lncRNA MIR4435-2HG promotes the progression of liver cancer by upregulating B3GNT5 expression
por: Zhu, Yungang, et al.
Publicado: (2022)

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1
por: Luo, Ping, et al.
Publicado: (2020)

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
por: Zhu, Lijuan, et al.
Publicado: (2020)

lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression
por: Yang, Tao, et al.
Publicado: (2022)

M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1
por: Li, Zhiyu, et al.
Publicado: (2023)

LncRNA MIR4435‐2HG functions as a ceRNA against miR‐125a‐5p and promotes neuroglioma development by upregulating TAZ
por: Shen, Wangzhen, et al.
Publicado: (2021)

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
por: Kong, Qinglei, et al.
Publicado: (2019)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
por: Li, Chaofeng, et al.
Publicado: (2022)

Fusobacterium nucleatum promotes epithelial‐mesenchymal transiton through regulation of the lncRNA MIR4435‐2HG/miR‐296‐5p/Akt2/SNAI1 signaling pathway
por: Zhang, Shuwei, et al.
Publicado: (2020)

lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
por: Zhu, Kai, et al.
Publicado: (2020)

N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation
por: Zhu, Yiqing, et al.
Publicado: (2023)

LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
por: Pei, Lu, et al.
Publicado: (2023)

Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils
por: Yu, Hongfei, et al.
Publicado: (2022)

Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer
por: Hu, Zhiquan, et al.
Publicado: (2022)

Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis
por: Gao, Li-Fei, et al.
Publicado: (2021)

Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
por: Ghasemian, Majid, et al.
Publicado: (2022)

Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis
por: Dong, Xinhua, et al.
Publicado: (2020)

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy
por: Ho, Kuo‐Hao, et al.
Publicado: (2021)

Knockdown of lncRNA MIR4435-2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β-catenin signaling pathway
por: Xing, Pengyi, et al.
Publicado: (2021)

MIR31HG, a potential lncRNA in human cancers and non-cancers
por: Ruan, Luxi, et al.
Publicado: (2023)

Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2021)

Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro
por: Wang, Ruijing, et al.
Publicado: (2020)

LncRNA LINC00665 Promotes Prostate Cancer Progression via miR-1224-5p/SND1 Axis
por: Chen, Wei, et al.
Publicado: (2020)

LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis
por: Guo, Jinlan, et al.
Publicado: (2021)

Long non-coding RNA MIR4435-2HG/microRNA-125a-5p axis is involved in myocardial ischemic injuries
por: Wang, Xiuling, et al.
Publicado: (2022)

Polymorphisms in lncRNA MIR2052HG and susceptibility to breast cancer in Chinese population
por: Yang, Hui, et al.
Publicado: (2021)

Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis
por: Li, Shaling, et al.
Publicado: (2022)

Long non-coding RNA MIR4435-2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR-383-5p/RBM3 axis
por: Wang, Shu, et al.
Publicado: (2021)

LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
por: Shi, Fan, et al.
Publicado: (2019)

LncRNA NEAT1 Promotes the Progression of Gastric Cancer Through Modifying the miR-1224-5p/RSF1 Signaling Axis
por: Yang, Luoluo, et al.
Publicado: (2020)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer
por: Li, Jun, et al.
Publicado: (2019)

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer
por: Ke, Dong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c0knbpfe2badqe3aq3rjnml290